Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losmapimod Effects on Macrophage Activity in Atherosclerosis
NCT00633022Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of losmapimod in atherosclerosis, sponsored by GSK. Started Jun 2008; status: completed.
02
Drugs
losmapimod
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00633022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00633022.